Navigation Links
UTHealth researchers gain insights into severe form of dwarfism
Date:9/3/2014

HOUSTON (Sept. 3, 2014) A better understanding of the pathology of a severe form of dwarfism as well as a possible window of treatment have been discovered by researchers at The University of Texas Health Science Center at Houston (UTHealth).

The preclinical research was published in a recent issue of the Journal of Bone and Mineral Research.

Pseudoachondroplasia (PSACH) is a disorder that affects the cells in the growth plate, resulting in dwarfism, limb deformities, joint pain and early onset osteoarthritis. Children with PSACH show no signs of it at birth. Slowing of the long bone growth begins around age 2 and the cellular damage becomes extensive by age 4. The disorder is caused by mutations in the cartilage oligomeric matrix protein (COMP) that is situated near cells known as chondrocytes, which play a key role in bone formation.

"By the time patients are in their late 20s, many have had both knees and hips replaced. They have severe joint pain and their mobility is very restricted," said first author Karen Posey, Ph.D., assistant professor of pediatrics at the UTHealth Medical School.

Previous studies of PSACH have been limited, relying on cultured PSACH cells or samples taken from human biopsies, and have not led to the development of feasible treatment options. Researchers recognized that they need a better method to study the disorder, which affects approximately 1 in 30,000 people.

"We generated a mouse with the human COMP gene that contains the most common mutation causing PSACH. Similar to how the disease manifests in humans, these genetically engineered mice appear normal at birth, but later show symptoms of PSACH, giving us a unique opportunity to potentially pinpoint when changes occur and when treatment may be most effective," Posey said.

The research team examined the mice at different stages of development to track the disorder's progression. They found that about two weeks
'/>"/>

Contact: Deborah Mann Lake
deborah.m.lake@uth.tmc.edu
University of Texas Health Science Center at Houston
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. UTHealth, French researchers discover gene defect for new syndrome
2. UTHealth research shows American Indians at greater risk of suicide after alcohol intoxication
3. UTHealth: Alcohol consumption may be in response to smoking cessation
4. UTHealth research: Low incidence of venous insufficiency in MS
5. UTHealth researchers say more rapid test for Group B strep successful
6. UTHealth research: Vermonts health care reform has lessons for other states
7. Sugar overload can damage heart according to UTHealth research
8. UTHealth, Swedish researchers uncover mystery in blood clotting disorder
9. UTHealth study aims to change traditional approach to preventing pressure ulcers
10. UTHealth named one of nations NIH stroke network centers
11. UTHealth program results in happier patients, lower costs in esophageal surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UTHealth researchers gain insights into severe form of dwarfism
(Date:8/4/2015)... ... August 05, 2015 , ... The Journal of Pain Research has ... corresponding author Professor Akiko Okifuji says “Both obesity and chronic pain are serious public ... say that one causes the other. Rather, there appear to be multiple factors that ...
(Date:8/4/2015)... ... August 04, 2015 , ... Atlantic Health System, one of the largest ... Fortune among the top five in their list of the 20 Best Workplaces in ... and Chilton Medical Centers, Goryeb Children’s Hospital and Atlantic Rehabilitation, is the highest-ranking company ...
(Date:8/4/2015)... ... August 04, 2015 , ... An article published July 27th by ... viable method for encouraging people to lose weight. Specifically the study compared control patients ... loss success, adding a financial incentive to the overall incentive of increased health. According ...
(Date:8/4/2015)... ... August 04, 2015 , ... PerceptiMed, Inc. ... Carmona, M.D., M.P.H., FACS, to its Board of Directors effective August 1, 2015. ... Dr. Carmona said. "I strongly believe in the mission of the company and ...
(Date:8/4/2015)... ... August 04, 2015 , ... One of the nation’s leading experts in chronic ... The Pain Antidote , which provides strategies for people who suffer from chronic ... Pain Treatment Program, wrote the book in conjunction with Katherine Ketcham, an author who ...
Breaking Medicine News(10 mins):Health News:The Association between Chronic Pain and Obesity published by Dove Medical Press 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 3Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 4Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 2Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 3
... uncovered a vital new biological clue that could lead ... that currently kills more than 60 per cent of ... Brain Tumour Research Centre, working on behalf of the ... role of the WNT biological pathway in central nervous ...
... Cite Compliance with Regulatory Bodies as Top Driver ... to a Sparta Systems sponsored survey unveiled at ... quality-related headlines have had little impact on managers, ... efforts. Instead, the majority of respondents - ...
... Millions of Dollars in Paper, Printing and Mailing Costs ... Corporation (NYSE: EMC ), the world leader ... Cross (IBC), a leading health insurer, has been named ... an independent research and consulting firm focused on the ...
... pharmaceutical and bio-sciences owner operators helps greatly ... facility in a validated stateHUNTSVILLE, Ala., March ... engineering software provider, introduced today SmartPlant(R) for ... the cost of construction and qualification/commissioning activities ...
... CareBETHESDA, Md., March 18 The Cystic Fibrosis Foundation ... leadership in improving the quality of care for people ... Quality Assurance (NCQA).The outlook for people with CF continues ... by the Foundation. In the 1950s, few children with ...
... a Long-Acting Interferon and Ribavirin Will Earn Decision ... in 2012, According to a New Report from ... one of the world,s leading research and advisory ... surveyed gastroenterologists and hepatologists identify a therapy,s effect ...
Cached Medicine News:Health News:Study finds biological clue in brain tumor development 2Health News:Life Sciences Quality Managers Seek to Expand Compliance Initiatives Despite Economic Pressures 2Health News:Life Sciences Quality Managers Seek to Expand Compliance Initiatives Despite Economic Pressures 3Health News:EMC Document Sciences(R) xPression(R) Helps Independence Blue Cross Win Recognition as 2009 Celent Model Carrier 2Health News:Intergraph(R) Introduces SmartPlant(R) for Life Sciences 2Health News:Intergraph(R) Introduces SmartPlant(R) for Life Sciences 3Health News:Intergraph(R) Introduces SmartPlant(R) for Life Sciences 4Health News:Cystic Fibrosis Foundation to Receive Prestigious Health Care Award 2Health News:In Hepatitis C Virus Treatment, Interviewed Experts Indicate That Telaprevir- and Boceprevir-Based Regimens Have Advantages Over Pegasys/Ribavirin in Sustained Virologic Response 2Health News:In Hepatitis C Virus Treatment, Interviewed Experts Indicate That Telaprevir- and Boceprevir-Based Regimens Have Advantages Over Pegasys/Ribavirin in Sustained Virologic Response 3
(Date:8/4/2015)... 2015 BioElectronics Corporation (OTC Pink: BIEL), ... Therapy medical devices, announced today that its registry ... trial device has been published in the prominent ... http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 chronic pain ... assessment.  Chronic pain is a ...
(Date:8/4/2015)... EDISON, N.J. , Aug. 4, 2015 /PRNewswire/ ... biopharmaceutical company focused on the development and commercialization ... Sapirstein , Chief Executive Officer, will present live ... DATE: Thursday, August 6, 2015 TIME: 12:15PM EDT ... will be a live, interactive online event where ...
(Date:8/4/2015)... 4, 2015  Ironshore Pharmaceuticals & Development, Inc. ... a company specializing in personalized medicine, to participate ... designed to evaluate the safety and efficacy of ... Attention-deficit/hyperactivity disorder (ADHD). This is Restore,s second clinical ... originally partnered with Ironshore in 2014 and continues ...
Breaking Medicine Technology:BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 3Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2
... voluntary recall of ALL lots of its Ketorolac Tromethamine Injection, USP ... NDC# 0517-0601-25 15 mg/mL ... This recall is in addition to the voluntary recall initiated on ... unexpired lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL ...
... a next-generation oncology diagnostics company focused on improving ... closed a $21 million series A financing. ... and included Bessemer Venture Partners, Physic Ventures and ... ) , On-Q-ity is developing diagnostics to determine ...
Cached Medicine Technology:American Regent Expands Voluntary Recall to Include All Lots of Ketorolac Tromethamine Injection, USP 15 mg/mL; 1mL Single Dose Vials 2Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 2
Spacelabs offers an approach that allows your telemetry and step-down units to configure systems to meet their telemetry requirements. Our modular telemetry system data are integrated into the depart...
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
ISI Ultra-Light Specialty Table offers the ultimate accessibility for surgeons, technicians and equipment during upper extremity surgeries....
Ademtechs Magnetic Beads are produced by encapsulation of a magnetic oil (patented technology). The magnetic content, uniform particle size, mono-dispersion properties, and the high surface area allo...
Medicine Products: